Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Host-specific response to HCV infection in the chimeric SCID-beige/Alb-uPA mouse model: role of the innate antiviral immune response.

Walters KA, Joyce MA, Thompson JC, Smith MW, Yeh MM, Proll S, Zhu LF, Gao TJ, Kneteman NM, Tyrrell DL, Katze MG.

PLoS Pathog. 2006 Jun;2(6):e59. Epub 2006 Jun 23.

2.

HCV induces oxidative and ER stress, and sensitizes infected cells to apoptosis in SCID/Alb-uPA mice.

Joyce MA, Walters KA, Lamb SE, Yeh MM, Zhu LF, Kneteman N, Doyle JS, Katze MG, Tyrrell DL.

PLoS Pathog. 2009 Feb;5(2):e1000291. doi: 10.1371/journal.ppat.1000291. Epub 2009 Feb 6.

3.

Chimeric mouse model for the infection of hepatitis B and C viruses.

Tesfaye A, Stift J, Maric D, Cui Q, Dienes HP, Feinstone SM.

PLoS One. 2013 Oct 14;8(10):e77298. doi: 10.1371/journal.pone.0077298. eCollection 2013.

4.

Hepatitis virus infection affects DNA methylation in mice with humanized livers.

Okamoto Y, Shinjo K, Shimizu Y, Sano T, Yamao K, Gao W, Fujii M, Osada H, Sekido Y, Murakami S, Tanaka Y, Joh T, Sato S, Takahashi S, Wakita T, Zhu J, Issa JP, Kondo Y.

Gastroenterology. 2014 Feb;146(2):562-72. doi: 10.1053/j.gastro.2013.10.056. Epub 2013 Oct 30.

PMID:
24184133
5.

Ultra-rapid cardiotoxicity of the hepatitis C virus protease inhibitor BILN 2061 in the urokinase-type plasminogen activator mouse.

Vanwolleghem T, Meuleman P, Libbrecht L, Roskams T, De Vos R, Leroux-Roels G.

Gastroenterology. 2007 Oct;133(4):1144-55. Epub 2007 Jul 10.

PMID:
17919490
6.

A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections.

Kosaka K, Hiraga N, Imamura M, Yoshimi S, Murakami E, Nakahara T, Honda Y, Ono A, Kawaoka T, Tsuge M, Abe H, Hayes CN, Miki D, Aikata H, Ochi H, Ishida Y, Tateno C, Yoshizato K, Sasaki T, Chayama K.

Biochem Biophys Res Commun. 2013 Nov 8;441(1):230-5. doi: 10.1016/j.bbrc.2013.10.040. Epub 2013 Oct 16.

PMID:
24140055
7.
8.

Practical evaluation of a mouse with chimeric human liver model for hepatitis C virus infection using an NS3-4A protease inhibitor.

Kamiya N, Iwao E, Hiraga N, Tsuge M, Imamura M, Takahashi S, Miyoshi S, Tateno C, Yoshizato K, Chayama K.

J Gen Virol. 2010 Jul;91(Pt 7):1668-77. doi: 10.1099/vir.0.019315-0. Epub 2010 Feb 17.

PMID:
20164258
9.

Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID mice.

Vanwolleghem T, Libbrecht L, Hansen BE, Desombere I, Roskams T, Meuleman P, Leroux-Roels G.

J Hepatol. 2010 Sep;53(3):468-76. doi: 10.1016/j.jhep.2010.03.024. Epub 2010 May 31.

PMID:
20591528
10.

Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera.

Meuleman P, Libbrecht L, De Vos R, de Hemptinne B, Gevaert K, Vandekerckhove J, Roskams T, Leroux-Roels G.

Hepatology. 2005 Apr;41(4):847-56.

PMID:
15791625
11.

Generation of Novel Chimeric Mice with Humanized Livers by Using Hemizygous cDNA-uPA/SCID Mice.

Tateno C, Kawase Y, Tobita Y, Hamamura S, Ohshita H, Yokomichi H, Sanada H, Kakuni M, Shiota A, Kojima Y, Ishida Y, Shitara H, Wada NA, Tateishi H, Sudoh M, Nagatsuka S, Jishage K, Kohara M.

PLoS One. 2015 Nov 4;10(11):e0142145. doi: 10.1371/journal.pone.0142145. eCollection 2015.

12.

Usefulness of humanized cDNA-uPA/SCID mice for the study of hepatitis B virus and hepatitis C virus virology.

Uchida T, Imamura M, Kan H, Hiraga N, Hayes CN, Tsuge M, Abe-Chayama H, Aikata H, Makokha GN, Miki D, Ochi H, Ishida Y, Tateno C, Chayama K.

J Gen Virol. 2017 May;98(5):1040-1047. doi: 10.1099/jgv.0.000726. Epub 2017 May 25.

PMID:
28141486
13.

Development of humanized mice for the study of hepatitis C virus infection.

Turrini P, Sasso R, Germoni S, Marcucci I, Celluci A, Di Marco A, Marra E, Paonessa G, Eutropi A, Laufer R, Migliaccio G, Padron J.

Transplant Proc. 2006 May;38(4):1181-4.

PMID:
16757300
14.

Lipoprotein profiles in SCID/uPA mice transplanted with human hepatocytes become human-like and correlate with HCV infection success.

Steenbergen RH, Joyce MA, Lund G, Lewis J, Chen R, Barsby N, Douglas D, Zhu LF, Tyrrell DL, Kneteman NM.

Am J Physiol Gastrointest Liver Physiol. 2010 Oct;299(4):G844-54. doi: 10.1152/ajpgi.00200.2010. Epub 2010 Jul 22. Erratum in: Am J Physiol Gastrointest Liver Physiol. 2011 Jan;300(1):G190. Douglas, Donna [added]Tyrrell, D Lorne J [corrected to Tyrrell, D Lorne].

15.

The human liver-uPA-SCID mouse: a model for the evaluation of antiviral compounds against HBV and HCV.

Meuleman P, Leroux-Roels G.

Antiviral Res. 2008 Dec;80(3):231-8. doi: 10.1016/j.antiviral.2008.07.006. Epub 2008 Aug 14. Review.

PMID:
18706933
16.

Construction of a single lentiviral vector containing tetracycline-inducible Alb-uPA for transduction of uPA expression in murine hepatocytes.

Bai J, Li J, Mao Q.

PLoS One. 2013 Apr 23;8(4):e61412. doi: 10.1371/journal.pone.0061412. Print 2013.

17.

Application of functional genomics to the chimeric mouse model of HCV infection: optimization of microarray protocols and genomics analysis.

Walters KA, Joyce MA, Thompson JC, Proll S, Wallace J, Smith MW, Furlong J, Tyrrell DL, Katze MG.

Virol J. 2006 May 25;3:37.

18.

Identification of Cholesterol 25-Hydroxylase as a Novel Host Restriction Factor and a Part of the Primary Innate Immune Responses against Hepatitis C Virus Infection.

Xiang Y, Tang JJ, Tao W, Cao X, Song BL, Zhong J.

J Virol. 2015 Jul;89(13):6805-16. doi: 10.1128/JVI.00587-15. Epub 2015 Apr 22.

19.

Animal model for study of human hepatitis viruses.

Chayama K, Hayes CN, Hiraga N, Abe H, Tsuge M, Imamura M.

J Gastroenterol Hepatol. 2011 Jan;26(1):13-8. doi: 10.1111/j.1440-1746.2010.06470.x. Review.

PMID:
21175788
20.

Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver-chimeric mice from infection with a homologous hepatitis C virus strain.

Vanwolleghem T, Bukh J, Meuleman P, Desombere I, Meunier JC, Alter H, Purcell RH, Leroux-Roels G.

Hepatology. 2008 Jun;47(6):1846-55. doi: 10.1002/hep.22244.

PMID:
18452146

Supplemental Content

Support Center